| 0.1511 0.001 (0.73%) | 04-23 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 0.24 | 1-year : | 0.3 |
| Resists | First : | 0.2 | Second : | 0.25 |
| Pivot price | 0.15  |
|||
| Supports | First : | 0.12 | Second : | 0.1 |
| MAs | MA(5) : | 0.14 |
MA(20) : | 0.16 |
| MA(100) : | 0.58 |
MA(250) : | 4.31 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 29.5 |
D(3) : | 25.3 |
| RSI | RSI(14): 41.2 |
|||
| 52-week | High : | 32 | Low : | 0.12 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ BIOL ] has closed above bottom band by 44.5%. Bollinger Bands are 82.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 34 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.16 - 0.16 | 0.16 - 0.16 |
| Low: | 0.15 - 0.15 | 0.15 - 0.15 |
| Close: | 0.15 - 0.15 | 0.15 - 0.15 |
BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, pain therapy, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.
Sat, 23 Mar 2024
BIOLASE, Inc. (NASDAQ:BIOL) Q4 2023 Earnings Call Transcript - Yahoo Finance
Fri, 22 Mar 2024
Earnings call: BIOLASE reports modest revenue gain and optimistic 2024 outlook - Investing.com
Fri, 22 Mar 2024
Why BIOLASE Shares Are Surging Friday | Markets Insider - Markets Insider
Thu, 21 Mar 2024
Biolase: Q4 Earnings Snapshot - Quartz
Thu, 15 Feb 2024
Biolase Raises $7 Million, Expands Capital and Ensures Compliance - TipRanks.com - TipRanks
Thu, 15 Feb 2024
BIOLASE, Inc. Announces Closing of $7.0 Million Public Offering - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 33 (M) |
| Shares Float | 32 (M) |
| Held by Insiders | 0.3 (%) |
| Held by Institutions | 8.2 (%) |
| Shares Short | 2,290 (K) |
| Shares Short P.Month | 246 (K) |
| EPS | -29.45 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.08 |
| Profit Margin | -42 % |
| Operating Margin | -34.7 % |
| Return on Assets (ttm) | -28.6 % |
| Return on Equity (ttm) | -602.9 % |
| Qtrly Rev. Growth | -4 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 1.47 |
| EBITDA (p.s.) | -0.42 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -14 (M) |
| Levered Free Cash Flow | -2 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | -0.1 |
| Price to Book value | -2.16 |
| Price to Sales | 0.1 |
| Price to Cash Flow | -0.36 |
| Dividend | 115.19 |
| Forward Dividend | 0 |
| Dividend Yield | 76234.2% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|